Literature DB >> 15234833

Generic antiretroviral drugs--will they be the answer to HIV in the developing world?

N Kumarasamy1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15234833     DOI： 10.1016/S0140-6736(04)16605-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care.

Authors:  Edward M Gardner; Moises E Maravi; Cornelis Rietmeijer; Arthur J Davidson; William J Burman
Journal:  Appl Health Econ Health Policy       Date:  2008       Impact factor: 2.561

Review 2.  Financial burden of health services for people with HIV/AIDS in India.

Authors:  N Kumarasamy; K K Venkatesh; K H Mayer; Kenneth Freedberg
Journal:  Indian J Med Res       Date:  2007-12       Impact factor: 2.375

3.  The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study.

Authors:  Eran Bendavid; Eric Leroux; Jay Bhattacharya; Nicole Smith; Grant Miller
Journal:  BMJ       Date:  2010-11-18

4.  Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.

Authors:  Jonathan Mermin; John P Ekwaru; Willy Were; Richard Degerman; Rebecca Bunnell; Frank Kaharuza; Robert Downing; Alex Coutinho; Peter Solberg; Lorraine N Alexander; Jordan Tappero; James Campbell; David M Moore
Journal:  BMJ       Date:  2011-11-09

5.  Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.

Authors:  Jeffrey S A Stringer; Albert J Mwango; Mark J Giganti; Lloyd Mulenga; Jens W Levy; Elizabeth M Stringer; Priscilla Mulenga; Michael S Saag; Patrick Musonda; Frank B Williams; Stewart E Reid; Benjamin H Chi
Journal:  Int J Epidemiol       Date:  2012-04       Impact factor: 7.196

6.  Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.

Authors:  Kartik K Venkatesh; J Biswas; N Kumarasamy
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

7.  Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015.

Authors:  N Kumarasamy; R Pendse
Journal:  Indian J Med Res       Date:  2014-12       Impact factor: 2.375
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.